Understanding the decline in HPV vaccination in Colombia: A population-based analysis of girls and parents in early rollout cohorts

Many countries in the world are facing challenges to reach the WHO proposed target of HPV vaccination of 90 % of girls by the age of 15. A population-based cross-sectional survey was conducted in Manizales, Colombia to identify sociodemographic factors and components of the health belief model relat...

Full description

Autores:
Cárdenas Garzón, Karen
Agudelo Fernández, María Cecilia
Tovar Aguirre, Olga Lucía
Reuter, Caroline
Arias Ortiz, Nelson Enrique
Franco Idarraga, Sandra Milena
Valverde Calderón, Kelly Paola
Agudelo Gamboa, Samuel
Garcés Palacio, Isabel Cristina
Arbeláez Montoya, María Patricia
Montoya Gómez, Nilton Edu
González Gómez, Difariney
Sánchez Vásquez, Gloria
Louie, Karly S.
Beddows, Simon
Tipo de recurso:
Article of investigation
Fecha de publicación:
2025
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/46860
Acceso en línea:
https://hdl.handle.net/10495/46860
Palabra clave:
Neoplasias del Cuello Uterino
Uterine Cervical Neoplasms
Colombia
Vacunas contra Papillomavirus
Papillomavirus Vaccines
Vacilación a la Vacunación
Vaccination Hesitancy
https://id.nlm.nih.gov/mesh/D002583
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D053918
https://id.nlm.nih.gov/mesh/D000088823
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description
Summary:Many countries in the world are facing challenges to reach the WHO proposed target of HPV vaccination of 90 % of girls by the age of 15. A population-based cross-sectional survey was conducted in Manizales, Colombia to identify sociodemographic factors and components of the health belief model related to HPV vaccination in the 2003, 2004, and 2005 birth cohorts of girls and their parents targeted by the national HPV vaccination program in 2012, 2013, and 2014. Complementary log-log generalized linear models were used to obtain adjusted Prevalence Ratios (aPR) and 95 % confidence intervals (CI). A lower prevalence of HPV vaccination was observed in girls of the 2004 (aPR 0.82; 95 % CI 0.71-0.92) and 2005 (aPR 0.61; 95 % CI 0.52-0.71) cohorts compared to the 2003 cohort. The higher scores of perceived benefits by girls (aPR 1.06; 95 % CI 1.05-1.08) or their parents (aPR 1.05; 95 % CI 1.03-1.06) were associated to a higher prevalence of HPV vaccination of the girls. Conversely, this prevalence decreased with perceived barriers by girls (aPR 0.94; 95 % CI 0.91-0.96) and parents (aPR 0.91; 95 % CI 0.88-0.94). Parent's education lower attainment, lower socioeconomic stratum, and subsidized (public) health insurance were related to decreased likelihood of HPV vaccination. The results suggest that campaigns for HPV vaccination require effective education strategies to improve public perception of the vaccine's safety and benefits. Decision-makers and implementers must address also other social determinants such as disparities in access to education by parents, the SES, and the type of health insurance to improve HPV vaccination coverage.